Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Nigeria tuberculosis diagnostics market was valued at USD 138.43 Million in 2025 and is expected to grow at a CAGR of 4.40%, reaching USD 212.93 Million by 2035. The market growth is driven by government initiatives and increasing integration of private laboratories into the national diagnostic network.

Key Market Trends and Insights

  • By product, molecular diagnostics are likely to lead the market in the forecast period.
  • By disease type, latent tuberculosis diagnostics accounted for around 40% of the market in the forecast period.
  • By end user, diagnostic labs held the largest market share in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 138.43 Million
  • Projected Market Size (2035): USD 212.93 Million
  • CAGR (2026-2035): 4.40%

Compound Annual Growth Rate

4.4%

Value in USD Million

2026-2035


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Nigeria Tuberculosis Diagnostics Market Overview

Tuberculosis (TB) diagnostics refers to the range of laboratory tests, molecular assays, imaging techniques, and clinical procedures used to detect Mycobacterium tuberculosis, the bacterium responsible for tuberculosis, determine the presence and extent of infection, and identify drug resistance to guide appropriate treatment. The market was valued at USD 138.43 Million in 2025, driven by the high burden of undiagnosed and underdiagnosed tuberculosis, expansion of molecular diagnostic testing, government-led TB case-finding initiatives, and international funding for diagnostic infrastructure.

Nigeria Tuberculosis Diagnostics Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Expansion of decentralized molecular testing to improve tuberculosis diagnostic access

In March 2026, Nigeria announced the nationwide rollout of over 1,000 Pluslife Mini Dock devices, alongside expanding GeneXpert and Truenat networks.

Market Restraints

Inadequate domestic funding and shortages of essential diagnostic supplies

In June 2026, reports highlighted USD 54 million in pending government counterpart funding and GeneXpert cartridge shortages across Nigerian facilities.

Market Opportunities

Expansion of near-point-of-care molecular testing and community-based screening

In June 2026, the Global Fund selected Nigeria among 13 countries for nearly 3 million portable molecular TB tests.

Nigeria Tuberculosis Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Nigeria Tuberculosis Diagnostics Market Growth Drivers

Expansion of Decentralized Molecular Testing to Enhance the Market Demand

The expansion of decentralized molecular testing is improving access to tuberculosis diagnosis across underserved communities in Nigeria. In March 2026, the Federal Government announced the nationwide deployment of over 1,000 Pluslife Mini Dock near-point-of-care diagnostic devices, alongside expanding GeneXpert and Truenat networks. These initiatives are strengthening diagnostic accessibility and supporting earlier TB detection.

Nigeria Tuberculosis Diagnostics Market Restraints

Inadequate and Unpredictable Funding for Diagnostic Consumables to Limit the Market Value

Insufficient domestic healthcare funding and dependence on external assistance are restricting the availability of essential tuberculosis diagnostic supplies in Nigeria. In June 2026, the Guardian Nigeria reported that the government had yet to release USD 54 million in counterpart funding for TB programmes. The report also highlighted GeneXpert cartridge shortages across monitored facilities. Such funding gaps and supply disruptions can delay testing, reduce diagnostic accessibility, and constrain the expansion of tuberculosis diagnostic services across the country.

Nigeria Tuberculosis Diagnostics Market Opportunities

Development of Near-Point-of-Care Molecular Testing and Community-Based Screening to Improve the Market Growth

The expansion of decentralized molecular testing is creating opportunities to improve tuberculosis diagnosis across underserved communities in Nigeria. In June 2026, the Global Fund selected Nigeria among 13 countries for nearly 3 million near-point-of-care molecular TB tests. Subsequently, in August 2026, Stop TB Partnership Nigeria outlined a RADxAR-TB implementation plan covering 250 facilities across 200 local government areas in 31 states. These initiatives are expected to improve diagnostic accessibility and support demand for molecular testing technologies.

Nigeria Tuberculosis Diagnostics Market Trends

The market is witnessing several key trends, including the growing adoption of decentralized molecular testing, AI-enabled screening technologies, and digitally integrated TB surveillance systems.

Shift Towards Decentralized Molecular Testing and AI-Enabled Digital Screening to Enhance the Market

The market is witnessing a shift towards decentralized molecular testing and AI-enabled digital screening, improving access to early TB detection. In March 2025, Nigeria's Federal Government announced the deployment of portable digital X-ray equipment and expansion of AI-enabled surveillance. Subsequently, in March 2026, the Ministry of Health initiated the rollout of over 1,000 Pluslife Mini Dock near-point-of-care diagnostic devices and strengthened electronic reporting systems. These developments are expanding diagnostic accessibility and supporting decentralized TB testing across Nigeria.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Nigeria Tuberculosis Diagnostics Market Share

Molecular Diagnostics are most Likely to Lead the Market by Diagnostics

Molecular diagnostics are gaining importance in the market, supported by the expansion of rapid testing infrastructure and increasing demand for early disease detection. According to the WHO Regional Office for Africa (2026), Nigeria has scaled up GeneXpert testing nationwide, improving access to rapid, bacteriologically confirmed diagnosis. These platforms offer greater diagnostic sensitivity than smear microscopy, faster results and opportunities for drug-resistance detection, supporting continued investment in instruments and recurring test consumables.

Leading Players in the Nigeria Tuberculosis Diagnostics Market

The key features of the market report include strategic initiatives by leading players. The major companies in the market are as follows:

Becton, Dickinson and Company (BD)

Becton, Dickinson and Company is a global medical technology company specializing in diagnostic systems, laboratory instruments and clinical testing solutions. Its portfolio includes microbiology products, specimen collection systems and molecular diagnostic technologies. The company supports tuberculosis detection through laboratory infrastructure, automated diagnostic workflows and solutions that strengthen infectious disease testing capabilities across healthcare systems.

FUJIFILM Holdings Corporation

FUJIFILM Holdings Corporation operates across healthcare, medical imaging, life sciences and diagnostic technologies. Its healthcare portfolio includes digital radiography, medical imaging systems and diagnostic solutions. The company contributes to tuberculosis detection through chest imaging technologies, supporting pulmonary screening, disease identification and clinical assessment, particularly in healthcare facilities seeking improved diagnostic efficiency and imaging capabilities.

Molbio Diagnostics Private Limited

Molbio Diagnostics is an Indian molecular diagnostics company specializing in portable, point-of-care testing platforms. Its Truenat system provides real-time PCR-based detection of tuberculosis and rifampicin resistance. The company focuses on decentralized molecular testing, enabling faster diagnosis in peripheral healthcare facilities and expanding access to tuberculosis diagnostics across resource-limited settings and emerging markets.

Qure.ai Technologies Private Limited

Qure.ai Technologies develops artificial intelligence-powered medical imaging solutions for automated interpretation of radiological scans. Its qXR platform analyses chest X-rays to identify abnormalities associated with pulmonary tuberculosis, supporting screening, triage and early detection. The company collaborates with healthcare organisations and public health programmes to expand AI-assisted tuberculosis screening, particularly in high-burden and resource-constrained settings.

Other key players in the market include Abbott, Qiagen N.V., Cepheid, Eiken Chemical Co., Ltd., F. Hoffmann-La Roche Ltd., and Hain Lifescience GmbH.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Nigeria Tuberculosis Diagnostics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Diagnostics

  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological & Antigen-Based Tests
  • Drug Susceptibility Testing

The market is supported by the expansion of rapid molecular testing, particularly GeneXpert-based platforms, alongside established microscopy and culture facilities. Government-led TB control programmes, increased screening of vulnerable populations, and international funding are strengthening diagnostic infrastructure. Rising demand for rapid rifampicin-resistance detection is also supporting advanced diagnostic adoption

Market Breakup by Disease Type

  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection

Pulmonary tuberculosis accounts for a substantial share of diagnostic demand because it represents the most common form of active TB and remains the primary driver of community transmission. Extrapulmonary testing is required to identify infections affecting organs beyond the lungs, while latent TB testing supports preventive treatment programmes among high-risk populations.

Market Breakup by End User

  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others

Hospitals represent an important end-user segment owing to their role in patient screening, clinical diagnosis, treatment initiation and management of complicated TB cases. Diagnostic laboratories support confirmatory testing through molecular assays, microscopy and culture-based techniques. Research laboratories contribute to diagnostic development, drug-resistance surveillance and epidemiological investigations, strengthening Nigeria's overall TB testing infrastructure.

Key Questions Answered in the Nigeria Tuberculosis Diagnostics Market Report

  • What was the Nigeria tuberculosis diagnostics market value in 2025?
  • What is the Nigeria tuberculosis diagnostics market forecast outlook for 2026-2035?
  • What are the major factors aiding the Nigeria tuberculosis diagnostics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major Nigeria tuberculosis diagnostics market trends?
  • Which diagnostics is expected to dominate the market segment?
  • Which disease type is projected to lead the market segment?
  • Which end user is anticipated to drive the market segment?
  • Who are the key players involved in the Nigeria tuberculosis diagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a structured mixed-methods research approach combining secondary research, market assessment, and data validation:

  • Primary Research: The research framework incorporates insights from healthcare professionals, tuberculosis specialists, diagnostic laboratory experts, public health officials, and procurement stakeholders to assess diagnostic accessibility, testing adoption, infrastructure requirements, and market challenges across Nigeria.
  • Secondary Research: Information is sourced from the Federal Ministry of Health Nigeria, WHO Regional Office for Africa, the Global Fund, Stop TB Partnership Nigeria, and The Guardian Nigeria. Company websites and product portfolios of Becton, Dickinson and Company, FUJIFILM, Molbio Diagnostics, and Qure.ai support the competitive and technology assessment.
  • Validation: Market findings are cross-checked against institutional announcements, company information, and published reports. Qualitative assessments are reviewed using structured top-down and bottom-up analytical approaches.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnostics
  • Disease Type
  • End User
Breakup by Diagnostics
  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological & Antigen-Based Tests
  • Drug Susceptibility Testing
Breakup by Disease Type
  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection
Breakup by End User
  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Abbott
  • Becton, Dickinson and Company (BD)
  • Qiagen N.V.
  • FUJIFILM Holdings Corporation
  • Cepheid
  • Molbio Diagnostics Private Limited
  • Hain Lifescience GmbH
  • Eiken Chemical Co., Ltd.
  • Qure.ai Technologies Private Limited
  • F. Hoffmann-La Roche Ltd

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us